NDC 51662-1456

BUPIVICAINE HYDROCHLORIDE

Bupivicaine Hydrochloride

BUPIVICAINE HYDROCHLORIDE is a Epidural; Infiltration; Intracaudal; Perineural Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co Llc, Dba Healthfirst. The primary component is Bupivacaine Hydrochloride.

Product ID51662-1456_99857946-6085-1bbd-e053-2a95a90af58c
NDC51662-1456
Product TypeHuman Prescription Drug
Proprietary NameBUPIVICAINE HYDROCHLORIDE
Generic NameBupivicaine Hydrochloride
Dosage FormInjection, Solution
Route of AdministrationEPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL
Marketing Start Date2019-12-12
Marketing CategoryANDA / ANDA
Application NumberANDA070583
Labeler NameHF Acquisition Co LLC, DBA HealthFirst
Substance NameBUPIVACAINE HYDROCHLORIDE
Active Ingredient Strength3 mg/mL
Pharm ClassesAmide Local Anesthetic [EPC],Amides [CS],Local Anesthesia [PE]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 51662-1456-1

30 mL in 1 VIAL, SINGLE-DOSE (51662-1456-1)
Marketing Start Date2019-12-12
NDC Exclude FlagN
Sample Package?N

Drug Details

Active Ingredients

IngredientStrength
BUPIVACAINE HYDROCHLORIDE2.5 mg/mL

Pharmacological Class

  • Amide Local Anesthetic [EPC]
  • Amides [CS]
  • Local Anesthesia [PE]

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.